SCHEMBL2766524

SCHEMBL2766524

Cc1cc(-c2ccccc2)nn1C(n1nc(-c2ccccc2)cc1C)n1nc(-c2ccccc2)cc1C.Cl[Mn]Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.44
KDM4E B2RXH2 5/20 0.44
NPC1 O15118 4/20 0.44
MAPT P10636 5/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 5/20 0.39
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NFKB1 P19838 1/20 0.39
HTT P42858 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
LDHA P00338 1/20 0.38
KMT2A Q03164 3/20 0.38
HSD17B10 Q99714 4/20 0.37
TSHR P16473 1/20 0.37
PTGS2 P35354 2/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 2/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2458919 0.93 RAB9A (0.49) RAB9AKDM4ENPC1MAPTPOLB
SCHEMBL2765541 0.87 SMN1; SMN2 (0.44) RAB9AKDM4ENPC1MAPTPOLB
Butadiene SCHEMBL2766054 0.84 RAB9A (0.42) RAB9AKDM4ENPC1MAPTPOLB
SCHEMBL2766550 0.81 MAPT (0.55) RAB9AKDM4ENPC1MAPTPOLB
SCHEMBL23986238 0.81 RAB9A (0.47) RAB9AKDM4ENPC1MAPTPOLB
SCHEMBL2454595 0.79 SMN1; SMN2 (0.49) RAB9AKDM4ENPC1MAPTALDH1A1
SCHEMBL2454381 0.77 DYRK1A (0.39) RAB9AKDM4ENPC1MAPTSMN1; SMN2
SCHEMBL2766205 0.75 NPC1 (0.43) RAB9AKDM4ENPC1MAPTALDH1A1
SCHEMBL2460517 0.75 CYP2A6 (0.53) KDM4EMAPTALDH1A1
SCHEMBL4985175 0.73 NPC1 (0.54) RAB9AKDM4ENPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1266911-B1 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL CO (JP) 2010-04-14 EP disclosed
US-6881802-B2 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-19 US disclosed
US-20030032743-A1 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-02-13 US disclosed
EP-1266911-A1 Catalyst for addition polymerization and process for producing an addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032743-A1 Catalyst for addition polymerization and process for producing an addition polymer BRAP, MCM4, BOLA2; BOLA2B RAB9A 3554/4885KDM4E 2623/4885NPC1 3681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.